{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-026568","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2024-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.751181+00:00","generated_at":"2026-06-05T18:37:24.703123+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Select Medical Q4 net income +63.9%, FY EPS $1.91; issues 2024 guidance","bullets":["Q4 revenue $1,658.9M (+4.9% YoY); net income $61.8M (+63.9%); EPS $0.36 (+63.6%).","FY 2023 revenue $6,664.1M (+5.2%); net income $299.7M (+51.4%); adjusted EPS $1.99 (+61.8%).","Critical illness recovery hospital segment FY Adjusted EBITDA surged 121% to $246.0M.","Board declared $0.125/share dividend payable March 13, 2024; $1B stock buyback authorized through 2025.","2024 outlook: revenue $6.9B–$7.1B, Adjusted EBITDA $830M–$880M, EPS $1.88–$2.18."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-026568","json":"https://secwatch.observer/filing/0001104659-24-026568.json","markdown":"https://secwatch.observer/filing/0001104659-24-026568.md","text":"https://secwatch.observer/filing/0001104659-24-026568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/0001104659-24-026568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/tm246929d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T18:37:24.703123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d14abb43938961d4c0451580dabe27c48941d2b","claim":"SELECT MEDICAL HOLDINGS CORP reported fourth quarter ended December 31, 2023 results: revenue $1,658.9 million, net income $61.8 million, EPS $0.36.","evidence_excerpt":"For the fourth quarter ended December 31, 2023, revenue increased 4.9% to $1,658.9 million, compared to $1,581.5 million for the same quarter, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/0001104659-24-026568-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$1,658.9 million"},{"label":"Net income","value":"$61.8 million"},{"label":"EPS","value":"$0.36"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c19cd1b65462b942d2dd54bd367aed2056443d7c","claim":"SELECT MEDICAL HOLDINGS CORP reported year ended December 31, 2023 results: revenue $6,664.1 million, net income $299.7 million, EPS $1.91.","evidence_excerpt":"For the year ended December 31, 2023, revenue increased 5.2% to $6,664.1 million, compared to $6,333.5 million for the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/0001104659-24-026568-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2023"},{"label":"Revenue","value":"$6,664.1 million"},{"label":"Net income","value":"$299.7 million"},{"label":"EPS","value":"$1.91"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}